18.50
+0.25
+(1.37%)
At close: 3:13:32 PM GMT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-1,527
-1,527
-1,109
-1,565
-927.96
Investing Cash Flow
1,110
1,110
-331
2,707
-350.35
Financing Cash Flow
--
--
485
--
1,687.38
End Cash Position
635
635
1,052
2,007
864.68
Capital Expenditure
--
--
-168
-194
-350.35
Issuance of Capital Stock
--
--
485
--
940.63
Free Cash Flow
-1,527
-1,527
-1,277
-1,759
-1,278.31
12/31/2020 - 9/9/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PBX.AQ ProBiotix Health Plc
12.23
+0.20%
ARDX.MX Ardelyx, Inc.
105.50
0.00%
C4X.F Valerio Therapeutics Société anonyme
0.0505
-2.88%
HQ1.MU Oruka Therapeutics Inc. R
9.60
+1.59%
NV3P.F NanoViricides, Inc.
1.1900
-1.65%
J7Z.DU Jazz Pharmaceuticals PLC
136.80
-0.04%
TRX.L Tissue Regenix Group plc
45.00
0.00%
PH4.F CStone Pharmaceuticals
0.4000
-8.68%
SBTX.L SkinBioTherapeutics plc
20.10
0.00%
1S9.SG Seres Therapeutics Inc
0.7094
+3.53%